高级检索
当前位置: 首页 > 详情页

miR-211-5p is down-regulated and a prognostic marker in bladder cancer

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Urinary Surgery, The Qujing No. 1 People's Hospital, Qujing, Yunnan Province, China
出处:
ISSN:

关键词: apoptosis bladder cancer histone deacetylase 9 microRNA post-transcriptional mechanism

摘要:
Background The micro RNA (miRNA)/histone deacetylase 9 (HDAC9) signaling axis has been reported to be involved in initiating and developing multiple malignant tumors. In the present study, we aimed to determine whether miR-211-5p serves as a post-transcriptional regulator in bladder cancer (BCa) cell proliferation and apoptosis by targeting HDAC9. Methods miRNA expression profiling of BCa tissues and para-carcinoma tissues was screened by miRNA microarray. After transfection with miR-211-5p mimics or short hairpin RNA of HDAC9 (sh-HDAC9), mRNA and protein expression was evaluated using a quantitative reverse transcription-polymerase chain reaction and western blotting, respectively. A bioinformatics algorithm was used, and a dual-luciferase reporter assay was performed to validate HDAC9 as a direct target of miR-211-5p. Cell proliferation was analyzed by the 3-(4, 5-dimethylthiazl2-yl)-2,5-diphenyltetazolium bromide (MTT) assay. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) detection was used to evaluate apoptosis in 5637 and T24 cells. A transwell assay was used to assess migration and invasion. Results miR-211-5p is down-regulated in BCa tumor tissues and cell lines. miR-211-5p is identified as an independent biomarker for predicting overall survival. HDAC9 is a direct target of miR-211-5p, and overexpression of miR-211-5p represses HDAC9 protein expressionin vitro. Overexpression of miR-211-5p or HDAC9 knockdown significantly inhibits proliferation, migration and invasion of 5637 and T24 cells, and also induces cell apoptosis. Conclusions miR-211-5p may play a role as a tumor suppressor and as a favourable prognostic marker in BCa.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 4 区 医学
小类 | 4 区 生物工程与应用微生物 4 区 遗传学 4 区 医学:研究与实验
最新[2025]版:
大类 | 4 区 医学
小类 | 3 区 生物工程与应用微生物 4 区 遗传学 4 区 医学:研究与实验
JCR分区:
出版当年[2019]版:
Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q2 GENETICS & HEREDITY Q2 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q2 GENETICS & HEREDITY Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Department of Urinary Surgery, The Qujing No. 1 People's Hospital, Qujing, Yunnan Province, China
通讯作者:
通讯机构: [1]Department of Urinary Surgery, The Qujing No. 1 People's Hospital, Qujing, Yunnan Province, China [*1]Department of Urinary Surgery, the Qujing No. 1 People's Hospital, No. 1 Yuanlin Road, Qujing 655000, Yunnan Province, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:87218 今日访问量:1 总访问量:717 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号